Collectively these data suggest that micro-CT imaging in conditional Nedd4-2−/− mice can be used for noninvasive testing of the in vivo effects of new therapeutic approaches or disease-relevant factors in both early and late IPF-like disease. The gene discussed is NEDD4; the disease is idiopathic pulmonary fibrosis.